Technologies and products are being developed at an extraordinary rate, and global competition is fierce. In this environment, life sciences companies need lawyers as innovative and commercially focused as they are. That’s why clients turn to Dechert. We apply our industry knowledge and commercial judgement to help our life sciences clients navigate their most complex and demanding transactional, intellectual property and litigation matters anywhere in the world. Whether guiding a start-up biotech through its first round of commercially significant funding, executing a strategic acquisition for a large pharmaceutical company, licensing a medical device company’s patents or winning antitrust, securities or patent disputes, our lawyers approach every matter with the resources of a major international firm and the focus and depth of a life sciences boutique.

Robert Darwin has a broad international practice focused on private equity and M&A. He is particularly known for his work with global life sciences and healthcare corporations and investors.

Robert Darwin Partner, Dechert LLP
Public Policy Projects is part of the Dorson Inform Group of companies which includes Dorson Transform.
  • Phone: 0207 8399305

Publications associated with PPP